AT186367B - Verfahren zur Herstellung hochkonzentrierter Injektionspräparate von Steroidhormonen - Google Patents
Verfahren zur Herstellung hochkonzentrierter Injektionspräparate von SteroidhormonenInfo
- Publication number
- AT186367B AT186367B AT186367DA AT186367B AT 186367 B AT186367 B AT 186367B AT 186367D A AT186367D A AT 186367DA AT 186367 B AT186367 B AT 186367B
- Authority
- AT
- Austria
- Prior art keywords
- production
- highly concentrated
- steroid hormones
- injection preparations
- concentrated injection
- Prior art date
Links
- 238000002347 injection Methods 0.000 title 1
- 239000007924 injection Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000003270 steroid hormone Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE186367T | 1951-05-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AT186367B true AT186367B (de) | 1956-08-10 |
Family
ID=29431690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT186367D AT186367B (de) | 1951-05-17 | 1952-04-02 | Verfahren zur Herstellung hochkonzentrierter Injektionspräparate von Steroidhormonen |
Country Status (1)
| Country | Link |
|---|---|
| AT (1) | AT186367B (de) |
-
1952
- 1952-04-02 AT AT186367D patent/AT186367B/de active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH311154A (de) | Verfahren zur Herstellung von geformten Gebilden. | |
| CH300957A (de) | Verfahren zur Herstellung von Halbzellstoff. | |
| AT175782B (de) | Verfahren zur Herstellung von Halbzellstoff | |
| CH469769A (de) | Verfahren zur Herstellung von Polybenzoxazindionen | |
| AT186367B (de) | Verfahren zur Herstellung hochkonzentrierter Injektionspräparate von Steroidhormonen | |
| AT192061B (de) | Verfahren zur Herstellung hochkonzentrierter Injektionspräparate von Steroidhormonen | |
| CH307970A (de) | Verfahren zur Herstellung von Chlorfluoräthenen. | |
| CH292070A (de) | Verfahren zur Herstellung von Ammoniumnitrilosulfonat. | |
| AT179289B (de) | Verfahren zur Herstellung von Halogenfluoräthenen | |
| AT193705B (de) | Verfahren zur Herstellung von Joghurtpräparaten | |
| AT177217B (de) | Verfahren zur Herstellung von Nährpräparaten | |
| AT182828B (de) | Verfahren zur Herstellung von ungesättigten Verbindungen der Androstanreihe | |
| AT177770B (de) | Verfahren zur Herstellung von Oxyphenylserinen | |
| AT173458B (de) | Verfahren zur Herstellung von 3-Pyridyl-carbinol | |
| AT172050B (de) | Verfahren zur Herstellung von N1-acylierten Aminoarylsulfonamiden | |
| CH316743A (de) | Verfahren zur Herstellung von Antidiazotaten | |
| AT176554B (de) | Verfahren zur Herstellung von neuem Dibutolactam | |
| AT171199B (de) | Verfahren zur Herstellung von Bauelementen | |
| AT173695B (de) | Verfahren zur Herstellung von 3-Fluor-4-oxy-phenylessigsäure | |
| AT179290B (de) | Verfahren zur Herstellung von Octochlorcyclopenten | |
| AT181492B (de) | Verfahren zur Herstellung von Halbzellstoff | |
| AT176115B (de) | Verfahren zur direkten Herstellung von Positiven | |
| AT178537B (de) | Verfahren zur direkten Herstellung von Positiven | |
| CH328074A (de) | Verfahren zur Herstellung von Tryptophan | |
| AT179291B (de) | Verfahren zur Herstellung von Oximen |